Hemoglobin fermented by engineered pichia pastoris and preparation method thereof
By inserting the key enzyme gene of the red bean hemoglobin gene and the heme synthesis pathway into Pichia cerevisiae, efficient biosynthesis of hemoglobin is achieved, solving the problem of insufficient plant hemoglobin synthesis efficiency and yield, improving the heme binding rate, and having commercial application prospects.
Patent Information
- Application Number
- CN202411479652.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-22
- Publication Date
- 2024-12-03
AI Technical Summary
In the prior art, the synthesis efficiency and yield of plant hemoglobin are insufficient, making it difficult to meet the color and nutritional needs of plant meat products.
By inserting the globin gene of hemoglobin and key enzyme genes of heme synthesis pathway in red bean Vigna angularis into the GS115 Pichia genome, a high-copy expression engineering strain was constructed, and the expression cassette was integrated using CRISPR/Cas9 gene editing method to achieve hemoglobin and heme Highly efficient biosynthesis.
It successfully increased the yield and heme binding rate of hemoglobin, achieved high-level synthesis of hemoglobin without the need for exogenous addition of precursors, solved the problem of insufficient plant-derived hemoglobin categories, and had wide commercial application prospects.
Smart Images

Figure CN119060170A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of biotechnology, and in particular to hemoglobin fermented by engineered Pichia pastoris and a preparation method thereof. Background Art
[0002] The demand for meat substitutes is rising due to the prosperity of the global population and consumers' growing awareness of health and environmental protection. As a high-protein, low-fat, environmentally friendly alternative, artificial meat is gradually becoming popular among consumers. In addition, the development of artificial meat technology can solve the problems of hormones, antibiotics, pesticide residues and zoonotic viruses, parasites and pathogenic bacteria that appear in traditional agriculture and animal husbandry, and can also save 75% of water, 87% of greenhouse gas emissions, and 95% of the land area required. However, at present, the taste, texture, color and taste of artificial meat are still significantly different from those of real meat, and hemoglobin needs to be added exogenously to impart color. In addition, exogenous addition of hemoglobin can also provide iron ions for plant meat products to meet specific nutritional needs.
[0003] Hemoglobin (HB) exists in prokaryotic and eukaryotic cells and is composed of heme cofactors and globin. According to its source and structure, hemoglobin can be mainly divided into animal hemoglobin, microbial hemoglobin and plant hemoglobin. Due to their potential pharmaceutical and nutritional value, they are used in different fields. For example, hemoglobin from Crocodylus siamensis has the potential to be an anti-inflammatory agent. Hemoglobin from Vitreoscilla has a significantly faster oxygen dissociation rate and is often used to enhance respiration and energy metabolism. As far as we know, among plant-derived hemoglobins, soy hemoglobin can greatly improve the taste and flavor of plant meat products and has been approved as a new synthetic food raw material for commercial use in the United States, Australia, New Zealand, Singapore and other countries.
[0004] The synthesis of hemoglobin is consistent with the synthesis of general proteins, but the synthesis of the heme contained in it consists of several reactions: (1) ALA production: In the mitochondria, glycine and succinyl-CoA are condensed to form ALA under the catalysis of 5-aminolevulinic acid synthase (ALAS, encoded by HEM1). (2) Porphobilinogen (PBG) production: After ALA is produced, it diffuses into the cytoplasm, and two ALA molecules are dehydrated and condensed to form one PBG molecule under the action of porphobilinogen synthase (PBGS, encoded by HEM2); (3) Uroporphyrinogen III
[0005] The formation of uroporphyrinogen III (UPG III) and coproporphyrinogen III (CPG III): In the cytoplasm, four molecules of PBG are deaminated and condensed into UPG III under the synergistic catalysis of porphobilinogen deaminase (PBGD, encoded by HEM3) and uroporphyrinogen III synthase (UROS, encoded by HEM4), and then coproporphyrinogen III CPG III is generated through the action of uroporphyrinogen decarboxylase (UROD, encoded by HEM12); (4) Formation of heme: CPG III re-enters the mitochondria through diffusion. Under the catalysis of coproporphyrinogen IIIoxidase (CPO, the encoding gene is HEM13), protoporphyrinogen IX (PPGIX) is generated, and then protoporphyrin IX (PPOIX) is generated through the action of protoporphyrinogen IX oxidase (PPO, the encoding gene is HEM14). The latter and Fe are catalyzed by heme synthase (Ferrochelatase, FECH, the encoding gene is HEM15) to generate heme. Heme is transferred from mitochondria to the cytoplasm and combines with globin to form hemoglobin.
[0006] In order to explore and efficiently biosynthesize plant hemoglobin to meet the needs of coloring plant meat while increasing nutrition, technicians in this field are committed to developing a new type of hemoglobin with a high heme binding rate and a preparation method thereof. Summary of the invention
[0007] In view of the above-mentioned defects of the prior art, the technical problem to be solved by the present invention is to develop a new type of hemoglobin with a high heme binding rate and a preparation method thereof.
[0008] To achieve the above object, the present invention provides a novel hemoglobin derived from red beans, wherein the globin nucleotide sequence of the hemoglobin is shown in SEQ ID NO: 1, and the globin amino acid sequence of the hemoglobin is shown in SEQ ID NO: 2.
[0009] Furthermore, the red bean is Vigna angularis.
[0010] The present invention also provides a method for biosynthesis of novel hemoglobin, comprising the following steps:
[0011] Step 1, inserting the gene encoding VaHB globin into the AOX1 site of the GS115 Pichia pastoris genome to construct a synthetic pathway for hemoglobin VaHB globin; the nucleotide sequence of the gene encoding VaHB globin is shown in SEQ ID NO: 1;
[0012] Step 2, continue to introduce the hemoglobin VaHB globin expression cassette on chromosome 4 of GS115 Pichia pastoris to obtain a high-copy globin expression engineering strain;
[0013] Step 3, integrating the key enzyme genes HEM1, HEM2, HEM3, HEM4, HEM12, HEM13, HEM14, and HEM15 encoding the heme synthesis pathway into the genome of the high-copy globin expression engineering strain obtained in step 2 to obtain a strain; the nucleotide sequence of the key enzyme gene HEM1 is shown in SEQ ID NO: 3, the nucleotide sequence of the key enzyme gene HEM2 is shown in SEQ ID NO: 4, the nucleotide sequence of the key enzyme gene HEM3 is shown in SEQ ID NO: 5, and the nucleotide sequence of the key enzyme gene HEM4 is shown in SEQ ID NO: 6;
[0014] Step 4: Induce fermentation using the strain constructed in step 3 to prepare hemoglobin globin and heme.
[0015] Furthermore, step 1 also includes: increasing the copy number at the genomic AOX1 site by means of PTVA.
[0016] Furthermore, in step 2, the hemoglobin VaHB globin expression cassettes are two expression cassettes, TEF1p-VaHB-AOX1t and AOX1p-VaHB-AOX1t; in the TEF1p-VaHB-AOX1t expression cassette, TEF1 is a promoter and AOX1 is a terminator; in the AOX1p-VaHB-AOX1t expression cassette, AOX1 is a promoter and AOX1 is a terminator. The nucleotide sequence of the AOX1 promoter is shown in SEQ ID NO: 23, the nucleotide sequence of the AOX1 terminator sequence is shown in SEQ ID NO: 24, and the nucleotide sequence of the TEF1 promoter sequence is shown in SEQ ID NO: 25.
[0017] Furthermore, step 3 also includes: a method for obtaining a linearized fragment of an expression cassette containing key enzyme genes HEM1, HEM2, HEM3, HEM4, HEM12, HEM13, HEM14, and HEM15 is PCR, and the universal primers are:
[0018] Upstream primer: 5'-Ctcaaacagaaaggccatgg-3'
[0019] Downstream primer: 5'-gtacccggggatcctctaga-3'
[0020] Further, the method comprises the following steps:
[0021] Step 1), after activating the HEM-ALL engineering strain, pick a single colony and inoculate it into a liquid culture medium to prepare a primary seed, and transfer it to a secondary seed bottle filled with liquid culture medium, and inoculate it into a 1L fermenter at an OD of 1-2; the genotype of the HEM-ALL engineering strain is HEM3-1-2-12-4-15::TEF1p-HEM14-AOX1t-AOX1p-HEM13-AOX1t, FragB-0067; the HEM-ALL engineering strain is obtained by integrating the expression cassette of the key enzyme gene of the heme synthesis pathway into the strain VaHB-H7-pTEF1-pAOX1 by means of CRISPR / Cas9 gene editing;
[0022] Step 2), the culture medium composition is YPDF culture medium, 30°C, the dissolved oxygen of the fermenter is set to 30%, and the regulation of dissolved oxygen is regulated in series with the stirring bar of the fermenter; the YPDF culture medium composition is: 4.25mL / L 85% phosphoric acid, 5g / L ammonium sulfate, 0.93g / L calcium sulfate, 18.2g / L potassium sulfate, 14.9g / L magnesium sulfate, 4.13g / L potassium hydroxide, and 40.0g / L glycerol;
[0023] Step 3) After culturing the YPDF medium in step 2) for 24 hours, 1% methanol by volume was added, and methanol was added every 24 hours. When the glycerol in the medium was exhausted, 70% glycerol by volume was added. When the bacterial OD 600 When the concentration reaches 100, stop adding glycerol and the fermentation time is 96-120h.
[0024] Furthermore, a method for biosynthesis of hemoglobin globin and heme comprises:
[0025] 1) Insert the gene encoding VaHB globin into the AOX1 locus of the GS115 Pichia pastoris genome to construct the synthesis pathway of hemoglobin VaHB globin;
[0026] 2) Continue to introduce the hemoglobin VaHB globin expression cassette into chromosome 4 of GS115 Pichia pastoris to obtain a high-copy globin expression engineered strain;
[0027] 3) Integrating the key enzyme genes HEM1, HEM2, HEM3, HEM4, HEM12, HEM13, HEM14, and HEM15 encoding the heme synthesis pathway into the genome of the high-copy engineered strain expressing VaHB globin obtained in step 2);
[0028] 4) Inducing fermentation using the strain constructed in step 3) to prepare hemoglobin globin and heme.
[0029] The present invention also provides a fermentation preparation method for a novel hemoglobin, comprising the following steps: integrating the expression cassette AOX1p-HEM1-AOX1t of the key enzyme gene of the heme synthesis pathway into the strains VaHB-H7 and VaHB-H7-pTEF1-pAOX1 by means of CRISPR / Cas9 gene editing to obtain the engineered strains VaHB-H7-H1, HEM1. The expression cassettes of key enzyme genes in the heme synthesis pathway, AOX1p-HEM1-AOX1t and TEF1p-HEM3-CYC1t, AOX1p-HEM12-AOX1t and TEF1p-HEM2-CYC1t, AOX1p-HEM15-AOX1t and TEF1p-HEM4-CYC1t, AOX1p-HEM13-AOX1t and TEF1p-HEM14-CYC1t, were successively integrated into the strain VaHB-H7-pTEF1-pAOX1 by CRISPR / Cas9 gene editing, and strains HEM3-1, HEM3-1-2-12, HEM3-1-2-12-4-15 and HEM-ALL were obtained. The terminator of the TEF1p-HEM3-CYC1t, TEF1p-HEM2-CYC1t, TEF1p-HEM4-CYC1t, and TEF1p-HEM14-CYC1t expression cassettes is CYC1, and the nucleotide sequence of CYC1 is shown in SEQ ID NO:26.
[0030] The invention also provides application of the novel hemoglobin as a food colorant.
[0031] The invention also provides application of the novel hemoglobin as a food flavoring agent.
[0032] Furthermore, the amino acid sequences and nucleotide sequences involved are shown in Table 1.
[0033] Table 1 Amino acid sequence and nucleotide sequence
[0034]
[0035]
[0036] In the preferred embodiment 1 of the present invention, the screening and identification process of hemoglobin globin is described in detail;
[0037] In another preferred embodiment 2 of the present invention, the expression amount optimization process of hemoglobin VaHB globin is described in detail;
[0038] In another preferred embodiment 3 of the present invention, the optimization process of heme expression is described in detail;
[0039] In another preferred embodiment 4 of the present invention, the expression process of hemoglobin VaHB in a 1L fermenter is described in detail.
[0040] The beneficial technical effects of the present invention are as follows:
[0041] The present invention utilizes engineered Pichia pastoris to identify and intracellularly produce a novel hemoglobin VaHB derived from Vigna angularis without the need for exogenous addition of expensive precursors. First, (1) several hemoglobins from different sources were screened, and the results showed that VaHB had better yield and activity during expression; (2) under the control of an inducible promoter, the VaHB globin expression cassette was integrated into some sites of Pichia pastoris, and post-transformational vector amplification (PTVA) was used to increase the copy number of the VaHB globin gene in the Pichia pastoris genome in a multi-copy and site-directed integration manner to promote VaHB globin expression; (3) thereafter, the heme biosynthesis pathway genes were overexpressed individually or in combination to increase the yield of VaHB. Without the supplementation of expensive precursors, the Pichia pastoris strain was engineered to synthesize VaHB at a high level, which has broad commercial application prospects.
[0042] The present invention screens hemoglobin from a new source and successfully ferments hemoglobin with a titer of 0.7 g / L, thereby solving the problem of insufficient varieties of currently used plant-derived hemoglobin.
[0043] The present invention screens the binding energy of protein and coenzyme by means of molecular docking, and theoretically explains the hemoglobin with high affinity to heme, and the heme binding rate is as high as 96%.
[0044] The present invention reconstructs the heme synthesis pathway and uses a combination of a constitutive promoter and an inducible promoter to improve the contact efficiency between the heme precursor and the enzyme that catalyzes its synthesis, thereby increasing heme synthesis by 101%.
[0045] The concept, specific structure and technical effects of the present invention will be further described below in conjunction with the accompanying drawings to fully understand the purpose, characteristics and effects of the present invention. BRIEF DESCRIPTION OF THE DRAWINGS
[0046] Figure 1 It is a MEGA7.0 phylogenetic tree analysis diagram of VaHB and other 10 monomeric hemoglobins according to a preferred embodiment 1 of the present invention;
[0047] Figure 2 It is the result of ESPript3.0 amino acid sequence comparison of VaHB, CcHB, GsHB and GmHB in a preferred embodiment 1 of the present invention;
[0048] Figure 3 It is a 3D model of VaHB, CcHB, and GsHB and a 2D map of molecular docking results of a preferred embodiment 1 of the present invention;
[0049] Figure 4 This is a diagram showing the sodium dodecyl sulfate-polyacrylamide gel electrophoresis and fermentation results of three purified hemoglobins according to a preferred embodiment 1 of the present invention;
[0050] Figure 5 The bacterial concentration of the strain after PTVA screening and the OD of the supernatant of the cell lysis solution of a preferred embodiment 2 of the present invention are 415 Analysis result graph;
[0051] Figure 6 This is a fermentation result diagram of a preferred embodiment 2 of the present invention;
[0052] Figure 7 This is a diagram showing the optimization results of hemoglobin expression in a preferred embodiment 3 of the present invention. DETAILED DESCRIPTION
[0053] The following describes several preferred embodiments of the present invention with reference to the drawings in the specification, so that the technical content is clearer and easier to understand. The present invention can be embodied in many different forms of embodiments, and the protection scope of the present invention is not limited to the embodiments mentioned in the text.
[0054] Example 1 Screening and identification of hemoglobin globin:
[0055] The amino acid sequence of hemoglobin GmHB from soybean Glycine max was used as a template and compared in the NCBI database. The 40 protein sequences ranked at the top in similarity were analyzed by phylogenetic tree using Mega7.0 software. The phylogenetic tree analysis of VaHB and other 10 monomeric hemoglobins is shown in the following figure. Figure 1As shown in the figure, VaHB, CcHB, and GsHB selected for use in the present invention are marked with triangles, and GmHB is marked with a circle. Hemoglobin GsHB from Glycine soja, hemoglobin CcHB from Cajanus cajan, and hemoglobin VaHB from Vigna angularis were screened in the same branch of soy hemoglobin GmHB globin as shown in Table 2. Their sequence similarities with soy hemoglobin are 91.67%, 84.83%, and 82.07%, respectively. In order to predict whether the selected hemoglobin globin has the properties of binding heme and oxygenation, sequence analysis and domain analysis (https: / / www.ebi.ac.uk / interpro / search / sequence / ) were performed on the three globins, and protein multiple sequence alignment was performed using ClustalX 2.1 software and ESPript (http: / / espript.ibcp.fr / ESPript / ESPript / ). The results showed that the selected hemoglobin molecules all have relatively conservative regions that bind to heme molecules and oxygen molecules. The amino acid sequence comparison results of VaHB, CcHB, GsHB and GmHB are as follows: Figure 2 As shown, the heme binding domain, i.e. the conserved region, is Figure 2 Sequence inside the rectangular frame.
[0056] Table 2 Hemoglobin globin sequences
[0057]
[0058]
[0059] Then the structures of the three globins were predicted using the Alphafold2 online website (https: / / colab.research.google.com / github / sokrypton / ColabFold / blob / main / AlphaFold2.ipynbto), and the whole protein molecular docking simulations of their protein structure models and heme molecules were carried out on the ROSIE (https: / / rosie.rosettacommons.org / ligand_docking) and CB-DOCK2 (https: / / cadd.labshare.cn / cb-dock2 / index.php) online websites, respectively, to explore their binding mechanism and binding energy with heme molecules. The docking results were observed using Discovery Studio 4.5 software. The results showed that VaHB globin, CcHB globin, and GsHB globin could successfully dock with heme molecules, and they mainly interacted with heme molecules through hydrogen bonds, hydrophobic forces, and electrostatic forces. Among them, the results of ROSIE docking are as follows: Figure 3 As shown. Due to the different docking software algorithms, the docking results are also different. Their minimum surface binding energy and the main amino acids of interaction are shown in Table 3. The data of the two docking results show that the minimum binding energy of the four proteins with heme is <-5kcal / mol. It is generally believed that when the binding energy is <-5.0kcal / mol (1kcal=4.2kJ), it indicates that the compound has a strong binding activity with the target; when the binding energy is <-7.0kcal / mol, it indicates that there is a strong binding activity between the two. The results show that the four proteins have a strong binding activity with heme. And the main forces are hydrogen bonds and hydrophobic forces. The potential binding sites are shown in Table 3.
[0060] Table 3 Analysis of docking results between hemoglobin and heme molecules
[0061]
[0062]
[0063] Secondly, using pPICZA (commercial plasmid, available from Thermo Fisher Scientific) plasmid as the backbone, three globin genome integration plasmids Plasmid1-3 were constructed. The gene fragments of VaHB, GsHB, and CcHB were artificially synthesized and used as templates for PCR amplification to obtain the gene fragments. The specific primers used for amplification are shown below.
[0064] VaHB:
[0065] Upstream primer: 5'-ATGGTTGCATTTAGTGATAA-3'
[0066] Downstream primer: 5'-caatgatgatgatgatgatg-3'
[0067] CcHB:
[0068] Upstream primer: 5'-ATGGGTGGATTTACTGAGAA-3'
[0069] Downstream primer: 5'-TGCGTATGCCTTCTTTATTG-3'
[0070] GsHB:
[0071] Upstream primer: 5'-ATGGGTGCTTTTACGGAAAA-3'
[0072] Downstream primer: 5'-GGCCTTTTTGATAGCAGCTG-3'
[0073] The PCR reaction system was: 1.5 μL of each primer, 1 μL of template, 25 μL of KOD Fx enzyme, 22.5 μL of sterile water, and a total system of 50 μL.
[0074] The reaction conditions of PCR were: pre-denaturation at 94°C for 5 min, denaturation at 95°C for 20 s, annealing at 60°C for 30 s, extension at 72°C for 60 s, 30 cycles, and post-extension at 72°C for 10 min. A gene fragment of approximately 0.45 Kb was recovered after agarose gel electrophoresis.
[0075] The amplified gene fragments were connected to the pPICZA cloning vector using seamless cloning technology, and the ligation products were transferred to E. coli DH5α competent cells, coated on LB medium solid plates (containing 50 μg / mL kanamycin), and cultured in a 37°C incubator for 16 hours. After that, the monoclones were picked to LB liquid medium containing 50 μg / mL kanamycin, and cultured in a 37°C shaker at a speed of 220 rpm for 12 hours. The monoclones were sequenced after positive verification and named pPICZA-VaHB, pPICZA-GsHB and pPICZA-CcHB. The plasmids were stored at -20°C for standby use. Plasmid information is shown in Table 4.
[0076] Table 4 Plasmid genotype
[0077]
[0078]
[0079] The linearized fragment of about 4.3 Kb was collected by agarose gel electrophoresis using Sac I endonuclease for digestion at 37°C for 12 h (the system was 2 μL Sac I, 30 μL plasmid solution, 18 μL Sac I Buffer). Based on the GS115 (commercial strain, available from Thermo Fisher Scientific), GS115-Δku70 was constructed using CRISPR / Cas9. The strain genotype is shown in Table 5. Competent cells were prepared by incubating the strain GS115-Δku70 on ice with 1 M sorbitol. 10 μL of the linearized fragment and the competent cells were transformed by electroporation using an electroporator, and the transformed cells were plated on a Yeast Extract Peptone Dextrose Medium (YPD) plate containing G418 resistance.
[0080] When colonies grow on the plate, pick the strain and design primers at both ends of the genome insertion site AOX1 for rapid PCR verification, and obtain a band with a size of about 5Kb. The engineered strains that can produce three types of hemoglobin globin were named VaHB, GsHB, and CcHB, respectively, and inoculated into 10mL of glycerol buffered complex medium (Buffered Glycerol-complex Medium, BMGY) induction medium containing 1% (v / v) G418 antibiotic (50mg / mL) for fermentation. When the OD600 value of the bacterial solution is 1, 1% (v / v) methanol is added as an inducer every 24h for induction and fermentation for 96h. Strain information is shown in Table 5
[0081] Table 5 Strain genotypes
[0082]
[0083] After the fermentation, the absorbance of the bacterial solution at 600 nm was measured first. Then the bacterial solution was centrifuged at 8000g for 10 minutes, the bacterial cells were collected, resuspended in 50mM phosphate buffered saline (PBS) with a pH of 8.0, and then ultrasonically disrupted in an ice water bath for 25 minutes (400W, 10s on, 10s off), and then centrifuged again at 8000g for 15 minutes to collect the supernatant, which was the crude protein solution. Based on the His tag fusion protein, the crude protein solution was purified by affinity chromatography using a Ni-NTA column, and the column was balanced with a low concentration of 10mM imidazole solution (10mM imidazole, 500mM NaCl, 50mM Tris-HCl), and then the weakly bound impurities were eluted with a 20mM imidazole solution (20mM imidazole, 500mM NaCl, 50mM Tris-HCl), and the target protein was eluted with a 200mM imidazole solution (200mM imidazole, 500mM NaCl, 50mM Tris-HCl), and the buffer elution component of this part was collected to obtain a solution of three purified hemoglobins. The protein purity and molecular weight were detected by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (Sodium dodecyl sulphate-polyacrylamide gel electrophoresis, SDS-PAGE), and the results were as follows: Figure 4 As shown in the figure, part a is the SDS-PAGE analysis of VaHB, CcHB, and GsHB after purification, part b is the color analysis, part c is the 300-600nm absorption spectrum analysis, and part d is the specific enzyme activity and bacterial concentration analysis of VaHB, CcHB, and GsHB. The results show that the recombinant protein can be purified by affinity column to obtain electrophoresis pure protein with a molecular weight of about 15-17Kda, which is consistent with the predicted results, that is, the target protein is obtained. Take 200μL of the eluted pure protein and use a microplate reader to measure OD 300-600 The absorption spectrum of Figure 4 As shown, different proteins have different specific absorbance values. Brandford reagent is used for protein color development, and bovine serum albumin is used to draw a protein concentration standard curve. 100 μL of Brandford reagent is added to 10 μL of sample, and the absorbance value is measured at 595 nm to determine the protein concentration.
[0084] The heme content was determined using 3,3′,5,5′-tetramethylbenzidine (TMB) horseradish peroxide colorimetric solution. 10 μL of sample was added with 100 μL of TMB reagent and incubated at 37°C for 20 min in the dark. The reaction was terminated with 2 M sulfuric acid and the OD was measured.450 The extinction coefficient of 59000 M-1 cm-1 was converted to the concentration of TMB-derived oxidation products by the Beer-Lambert law.
[0085] Enzyme activity is defined as the amount of enzyme required to produce 1 μM TMB derivative per minute under standard conditions. The specific activity of the purified enzyme is: enzyme activity (U) / purified enzyme protein content (mg), and the specific activity of the crude enzyme is enzyme activity (U) / crude enzyme solution volume (mL). The results showed that the specific activities of VaHB, CcHB and GsHB reached 127.68U / mL, 95.66U / mL and 95.03U / mL, so VaHB with better activity was selected as the subject of subsequent experiments.
[0086] The heme determination kit (product number: EU2610) of Wuhan Fine Biotechnology Co., Ltd. was used to determine the heme in the purified hemoglobin solution. The heme calculation method was: the molar concentration of heme in the purified protein solution / the molar concentration of the purified protein molecule.
[0087] Example 2 Optimization of the expression level of hemoglobin VaHB globin
[0088] In order to increase the expression of hemoglobin VaHB globin, the copy number was increased by PTVA at the AOX1 site of the genome. First, a plasmid Plasmid 4 containing the antibiotic hygromycin B gene was constructed, and then the plasmid was linearized by SacⅠ and transformed by the previous method to obtain the engineered strain VaHB-R2. Then, based on this strain, post-transformational vector amplification (PTVA) was performed by increasing the concentrations of antibiotic G418 and hygromycin B. The antibiotic concentrations used were 1000, 1500, 2000, 2500, and 3000 ug / mL, respectively. After PTVA, the transformed bacterial liquid was streaked onto 3000 ug / mL G418 and hygromycin B plates, and ten colonies were picked for fermentation and named VaHB-H1~10 and VaHB-G1~10. The fermented bacterial liquid and the supernatant of the cell lysate were subjected to OD 600 and OD 415 The results showed that the expression levels of VaHB globin with different copy numbers were significantly different, and the colors of the fermentation broth and the cell lysis broth were also significantly different. The strain VaHB-G4 obtained by PTVA with G418 had a higher globin yield, and the strain VaHB-H7 obtained by PTVA with hygromycin B had a higher globin yield. The bacterial concentration of the strain after PTVA screening and the OD of the supernatant of the cell lysis broth were 415 The analysis results are as follows Figure 5 The plasmid information is shown in Table 4, and the strain information is shown in Table 5.
[0089] In order to further improve the expression of hemoglobin, two expression cassettes, TEF1p-VaHB-AOX1t and AOX1p-VaHB-AOX1t, were inserted into the upstream of chromosome PAS_chr2-1_0437 and upstream of PAS_chr3_1029 of VaHB-H7 by CRISPR / Cas9 (the transformation method was the same as above, and the gRNAs selected were gcggcagtaattgatatcgt and ttttaagatttcaatcttga, respectively). The required plasmids were Plasmid 5-8 to obtain the engineered strains VaHB-H7-pTEF1 and VaHB-H7-pTEF1-pAOX1, which were then fermented to verify the hemoglobin production. The results showed that the OD of VaHB-H7-pTEF1-pAOX1 and VaHB-H7-pTEF1-pAOX1 was 2.3447 W / m, 1.3317 W / m, and 1.3717 W / m. 415 The value was high, so VaHB-H7 and VaHB-H7-pTEF1-pAOX1 were selected for the insertion of the enzyme encoding gene required for subsequent heme synthesis. CRISPR / Cas9 was used to insert ALA synthase HEM1 on chromosome 1 of the engineered strains VaHB-H7 and VaHB-H7-pTEF1-pAOX1. The fermentation results showed that OD 415 The redox activity of hemoglobin has been significantly improved, such as Figure 6 As shown, part a shows the effect of inserting two additional VaHB expression cassettes and a HEM1 expression cassette on hemoglobin production, and part b shows the effect of strain color. The plasmid information used is shown in Table 4, and the strain information is shown in Table 5.
[0090] Example 3 Optimization of heme expression
[0091] First, eight plasmid vectors expressing globin and CRISPR / Cas9 plasmid Plasmid 9-20 were constructed (Table 4). The genome of Pichia pastoris was extracted and used as a template for PCR amplification to obtain gene fragments. The specific primers used for amplification are shown below.
[0092] HEM1:
[0093] Upstream primer: 5'-ATGGAGTTTGTCGCCCGTCA-3'
[0094] Downstream primer: 5'-ctacaatctgactcctgatg-3'
[0095] HEM2:
[0096] Upstream primer: 5'-ATGGTGCATAAGGCTGAATA-3'
[0097] Downstream primer: 5'-tcattcagataaccactcca-3'
[0098] HEM3:
[0099] Upstream primer: 5'-atgttatctccagtatcaca-3'
[0100] Downstream primer: 5'-ttaatgtaaaccctcttcct-3'
[0101] HEM4:
[0102] Upstream primer: 5'-atgccaaaagccattcttct-3'
[0103] Downstream primer: 5'-ttagtgcactttttgtatag-3'
[0104] HEM12:
[0105] Upstream primer: 5'-ATGAGTAGATTTCCAGAAACT-3'
[0106] Downstream primer: 5'-ctattgagatccaatgcgat-3'
[0107] HEM13:
[0108] Upstream primer: 5'-ATGGCCATCGACTCTGATAT-3'
[0109] Downstream primer: 5'-tcatacccattcaataggat-3'
[0110] HEM14:
[0111] Upstream primer: 5'-ATGCTGAAAAGTTCTTGCACC-3'
[0112] Downstream primer: 5'-ttaaatgccactgagggtag-3'
[0113] HEM15:
[0114] Upstream primer: 5'-ATGCTTAACCGTCGTTTCCA-3'
[0115] Downstream primer: 5'-tcaatgggctctgaaaaact-3'
[0116] The PCR reaction system was: 1.5 μL of each primer, 1 μL of template, 25 μL of KOD Fx enzyme, 22.5 μL of sterile water, and a total system of 50 μL.
[0117] The reaction conditions of PCR were as follows: pre-denaturation at 94°C for 5 min, denaturation at 95°C for 20 s, annealing at 60°C for 30 s, extension at 72°C for 60 s, 30 cycles of reaction, and post-extension at 72°C for 10 min. Gene fragments with a size range of 1-2 Kb were recovered after agarose gel electrophoresis.
[0118] Using pUC19 (commercial plasmid, available from Sangon Biotech) plasmid as the backbone, the amplified gene fragment and the backbone were connected by seamless cloning technology, and the connection product was transferred into E. coli DH5α competent cells, coated on LB medium solid plate (containing 50μg / mL kanamycin), cultured in 37℃ incubator for 16h, and then single clones were picked into LB liquid medium containing 50μg / mL kanamycin, and cultured in a 37℃ shaker at 220rpm for 12h. The single clone was sequenced after positive verification. The plasmid was stored at -20℃ for future use. Detailed plasmid information is shown in Table 4.
[0119] To solve the limitation of hemoglobin synthesis caused by insufficient heme supply, the expression cassettes of key enzyme genes in the heme synthesis pathway, AOX1p-HEM1-AOX1t and TEF1p-HEM3-CYC1t, AOX1p-HEM12-AOX1t and TEF1p-HEM2-CYC1t, AOX1p-HEM15-AOX1t and TEF1p-HEM4-CYC1t, AOX1p-HEM13-AOX1t and TEF1p-HEM14-CYC1t, were successively integrated into the heme synthesis pathway by CRISPR / Cas9 gene editing. The strains VaHB-H7 and VaHB-H7-pTEF1-pAOX1 (the gRNAs selected were gcaagatggttaaaaggtga, caactcgaattatagtggcg, tattaaaaaagacgatccc, caacgttggatgcgaaacac, respectively), and the strains VaHB-H7-H1, HEM1, HEM3-1, HEM3-1-2-12, HEM3-1-2-12-4-15, and HEM-ALL were obtained. The plasmid information is shown in Table 4, and the strain information is shown in Table 5. The linearized fragment containing the HEM expression cassette was obtained by PCR, and the universal primers were:
[0120] Upstream primer: 5'-Ctcaaacagaaaggccatgg-3'
[0121] Downstream primer: 5'-gtacccggggatcctctaga-3'
[0122] The results showed that after the heme synthesis content increased, the hemoglobin production was improved to a certain extent, and the color of the culture medium gradually deepened, such as Figure 7 As shown, part a shows the effect of the insertion of the heme synthase gene expression cassette on the hemoglobin titer, part b shows the color of the fermentation broth, part c shows the color of the strain, and part d shows the SDS-PAGE analysis of VaHB synthesized by different engineered strains after purification. The final VaHB titer reached 0.12g / L, the heme production increased by 101% and the heme binding rate reached 96%.
[0123] Example 4 Expression of hemoglobin VaHB in a 1L fermenter
[0124] After the HEM-ALL engineered strain was activated on a YPD (G418 resistance) plate, a single colony was picked and inoculated into 1 mL of YPD liquid medium (G418 resistance) to prepare primary seeds, cultured overnight at 30°C and 250 rpm for 24 h until the OD reached between 1 and 2, and then transferred to a secondary seed bottle containing YPD liquid medium (G418 resistance) according to an inoculum size of 1% (v / v), cultured at 30°C and 250 rpm for 12 h, and when the OD was 1-2, inoculated into a 1 L fermenter according to an inoculum size of 5-10% (v / v). The medium composition is YPDF medium ((4.25mL / L 85% phosphoric acid, 5g / L ammonium sulfate, 0.93g / L calcium sulfate, 18.2g / L potassium sulfate, 14.9g / L magnesium sulfate, 4.13g / L potassium hydroxide, and 40.0g / L glycerol), 30°C, the dissolved oxygen of the fermenter is set to 30%, and the regulation of dissolved oxygen is regulated in series with the stirring bar of the fermenter. After culturing in the YPDF medium for 24h, 1% (v / v) methanol is added, and methanol is added every 24h thereafter. When the glycerol in the basic salt medium is exhausted, 70% (v / v) glycerol (700mL glycerol, 288mL water, 12mL PTM1 trace element solution) is added by volume. The method of adding glycerol is as follows: 8mL / h is added from 0 to 8h, 16mL / h is added from 9 to 16h, and 24mL / h is added after 17h. When the bacterial OD 600 When the concentration of glycerol reaches 100, the addition of glycerol is stopped, and the fermentation time is 96-120 hours. After the fermentation is completed, a part of the fermentation liquid is centrifuged (10000r / min, 5min), and crushed and purified according to the above method. After purification, the concentration of VaHB is measured, and its titer is 0.7g / L.
[0125] The preferred specific embodiments of the present invention are described in detail above. It should be understood that ordinary technicians in the field can make many modifications and changes based on the concept of the present invention without creative work. Therefore, all technical solutions that can be obtained by technicians in the technical field based on the concept of the present invention through logical analysis, reasoning or limited experiments on the basis of the prior art should be within the scope of protection determined by the claims.
Claims
1. A novel hemoglobin derived from red beans, characterized in that: The nucleotide sequence of the globin in the hemoglobin is shown in SEQ ID NO: 1, and the amino acid sequence of the globin is shown in SEQ ID NO:
2.
2. The novel hemoglobin according to claim 1, characterized in that The red bean is Vigna angularis.
3. The method for biosynthesis of novel hemoglobin according to claim 1, characterized in that: The method comprises the following steps: Step 1, inserting the gene encoding VaHB globin into the AOX1 site of the GS115 Pichia pastoris genome to construct a synthetic pathway for hemoglobin VaHB globin; the nucleotide sequence of the gene encoding VaHB globin is shown in SEQ ID NO: 1; Step 2, continue to introduce the hemoglobin VaHB globin expression cassette on chromosome 4 of GS115 Pichia pastoris to obtain a high-copy globin expression engineering strain; Step 3, integrating the key enzyme genes HEM1, HEM2, HEM3, HEM4, HEM12, HEM13, HEM14, and HEM15 encoding the heme synthesis pathway into the genome of the high-copy globin expression engineering strain obtained in step 2 to obtain a strain; the nucleotide sequence of the key enzyme gene HEM1 is shown in SEQ ID NO: 3, the nucleotide sequence of the key enzyme gene HEM2 is shown in SEQ ID NO: 4, the nucleotide sequence of the key enzyme gene HEM3 is shown in SEQ ID NO: 5, and the nucleotide sequence of the key enzyme gene HEM4 is shown in SEQ ID NO: 6; Step 4: Induce fermentation using the strain constructed in step 3 to prepare hemoglobin globin and heme.
4. The biosynthetic method according to claim 3, characterized in that The step 1 also includes: increasing the copy number at the AOX1 site of the genome by means of PTVA.
5. The biosynthetic method according to claim 3, characterized in that The hemoglobin globin VaHB expression cassettes in step 2 are two expression cassettes, TEF1p-VaHB-AOX1t and AOX1p-VaHB-AOX1t; in the TEF1p-VaHB-AOX1t expression cassette, TEF1 is a promoter and AOX1 is a terminator; in the AOX1p-VaHB-AOX1t expression cassette, AOX1 is a promoter and AOX1 is a terminator; the nucleotide sequence of the AOX1 promoter is shown in SEQ ID NO: 23, the nucleotide sequence of the AOX1 terminator sequence is shown in SEQ ID NO: 24, and the nucleotide sequence of the TEF1 promoter sequence is shown in SEQ ID NO:
25.
6. The biosynthetic method according to claim 3, characterized in that: The step 3 further comprises: a method for obtaining a linearized fragment of the expression cassette containing the key enzyme genes HEM1, HEM2, HEM3, HEM4, HEM12, HEM13, HEM14, and HEM15 is PCR, and the universal primers are: Upstream primer: 5'-Ctcaaacagaaaggccatgg-3' Downstream primer: 5'-gtacccggggatcctctaga-3'.
7. The fermentation method for preparing the novel hemoglobin according to claim 1, characterized in that: The method comprises the following steps: Step 1), after activating the HEM-ALL engineering strain, pick a single colony and inoculate it into a liquid culture medium to prepare a primary seed, and transfer it to a secondary seed bottle containing the liquid culture medium, and inoculate it into a 1L fermenter at an OD of 1-2; the genotype of the HEM-ALL engineering strain is HEM3-1-2-12-4-15::TEF1p-HEM14-AOX1t-AOX1p-HEM13-AOX1t, FragB-0067; the HEM-ALL engineering strain is obtained by integrating the expression cassette of the key enzyme gene of the heme synthesis pathway into the strain VaHB-H7-pTEF1-pAOX1 by means of CRISPR / Cas9 gene editing; Step 2), the culture medium composition is YPDF culture medium, 30°C, the dissolved oxygen of the fermenter is set to 30%, and the regulation of dissolved oxygen is regulated in series with the stirrer of the fermenter; the YPDF culture medium composition is: 4.25mL / L 85% phosphoric acid, 5g / L ammonium sulfate, 0.93g / L calcium sulfate, 18.2g / L potassium sulfate, 14.9g / L magnesium sulfate, 4.13g / L potassium hydroxide, and 40.0g / L glycerol; Step 3) After culturing the YPDF medium in step 2) for 24 hours, 1% methanol by volume was added, and methanol was added every 24 hours. When the glycerol in the medium was exhausted, 70% glycerol by volume was added. When the bacterial OD 600 When the concentration reaches 100, stop adding glycerol and the fermentation time is 96-120h.
8. The fermentation method for preparing the novel hemoglobin according to claim 7, characterized in that: The method comprises the following steps: integrating the expression cassette AOX1p-HEM1-AOX1t of the key enzyme gene of the heme synthesis pathway into the strains VaHB-H7 and VaHB-H7-pTEF1-pAOX1 by means of CRISPR / Cas9 gene editing to obtain the engineered strains VaHB-H7-H1, HEM1; integrating the expression cassettes AOX1p-HEM1-AOX1t and TEF1p-HEM3-CYC1t, AOX1p-HEM12-AOX1t and TEF1p-HEM2-CYC1t, AOX1p-HEM15-AOX1t and TEF1p-HEM4-CYC1 t, AOX1p-HEM13-AOX1t and TEF1p-HEM14-CYC1t were successively integrated into the strain VaHB-H7-pTEF1-pAOX1 by CRISPR / Cas9 gene editing to obtain strains HEM3-1, HEM3-1-2-12, HEM3-1-2-12-4-15 and HEM-ALL; wherein the terminator of the TEF1p-HEM3-CYC1t, TEF1p-HEM2-CYC1t, TEF1p-HEM4-CYC1t, and TEF1p-HEM14-CYC1tCYC1 expression cassette is CYC1, and the nucleotide sequence of the CYC1 is shown in SEQ ID NO:
26.
9. Use of the novel hemoglobin as claimed in claim 1 as a food colorant.
10. Use of the novel hemoglobin as claimed in claim 1 as a food flavoring agent.
Citation Information
Patent Citations
Methods and compositions for affecting the flavor and aroma profile of consumables
CN105050414A
Leghemoglobin GmLbc2 gene involved in symbiotic nodulation of leguminous plants and its application
CN110093355A
Expression cassette of bean hemoglobin, expression vector containing expression cassette, genetically engineered bacterium and application of genetically engineered bacterium
CN115725634A
Construction and application of pichia pastoris chassis strain for synthesizing high-activity heme protein
CN116790395A
Method for producing (R)-lavandulol and acetate through biosynthesis
CN116926130A
Cited By
Method for expressing protein through kluyveromyces marxianus bidirectional promoter
CN120424974A
